CureVac

Yahoo Finance • last month

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued and outstanding shares, tendered prior to the expiration of the initial offering periodThe su... Full story

Yahoo Finance • last month

BioNTech erfüllt Mindestannahmebedingungen im Rahmen des Umtauschangebots für CureVac-Aktien

Mindestannahmebedingung für das Angebot wurde erfüllt; es wurden vor Ablauf der ursprünglichen Angebotsfrist insgesamt 184.071.410 CureVac-Aktien angedient, was etwa 81,74 % der ausgegebenen und im Umlauf befindlichen CureVac-Aktien entspr... Full story

Yahoo Finance • last month

BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3

[Mature female virologist examining test tube while working in laboratory] Maskot * BioNTech SE (BNTX [https://seekingalpha.com/symbol/BNTX]) on Wednesday announced [https://seekingalpha.com/pr/20320982-biontech-shares-progress-on-excha... Full story

Yahoo Finance • last month

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025, due to operational deadlines.Exchange ratio of 0.05363 of a BioNTech Ame... Full story

Yahoo Finance • last month

BioNTech informiert über Fortschritte im Rahmen des Umtauschangebots für CureVac-Aktien und weist auf Ablauf des Angebots am 3. Dezember 2025 um 15 Uhr MEZ hin

Ablauf des Angebots am 3. Dezember 2025 um 15 Uhr MEZ (9:00 Uhr EST); CureVac-Aktionärinnen und -Aktionären wird empfohlen, ihre Aktien aufgrund operativer Fristen bis spätestens 3. Dezember 2025, 0:00 Uhr MEZ (2. Dezember 2025 um 18:00 Uh... Full story

Yahoo Finance • 2 months ago

CureVac Q3 Earnings Decline

(RTTNews) - CureVac N.V. (CVAC), a biotech company, Monday reported lower earnings and revenue for the third quarter compared to the same period last year. Quarterly earnings decreased to 273.2 million euro or 1.21 euro per share from 338... Full story

Yahoo Finance • 2 months ago

Washington state resident dies from bird flu strain never before detected in humans

[Bird Flu Quarantine Tape Barrier Before Defocused Background] MicroStockHub The Washington State Department of Health has announced that H5N5, a bird flu strain that has never been detected in humans globally, led to the death of an olde... Full story

Yahoo Finance • 3 months ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its oncology strategyCureVac shareholders re... Full story

Yahoo Finance • 3 months ago

BioNTech beginnt öffentliches Umtauschangebot für alle ausstehenden Aktien von CureVac N.V.

Geplante Übernahme soll Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer Meilenstein in der Umsetzung von BioNTechs Onkologie-StrategieCureVac-Aktionär... Full story

Yahoo Finance • 5 months ago

CureVac NV earnings missed by €0.21, revenue fell short of estimates

Investing.com - CureVac NV (NASDAQ: CVAC) reported second quarter EPS of €-0.260, €0.21 worse than the analyst estimate of €-0.046. Revenue for the quarter came in at €1.25M versus the consensus estimate of €34.59M. CureVac NV’s stock pri... Full story

Yahoo Finance • 5 months ago

CureVac BV reports Q2 results

* CureVac BV press release [https://seekingalpha.com/pr/20202438-curevac-announces-financial-results-for-the-second-quarter-and-first-half-of-2025-and] (NASDAQ:CVAC [https://seekingalpha.com/symbol/CVAC]): Q2 Revenues amounted to €1.2 mi... Full story

Yahoo Finance • 5 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

BioNTech SE Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific antibody candidate targeting PD... Full story

Yahoo Finance • 6 months ago

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why

CureVac N.V. (NASDAQ:CVAC) is among the 13 Best German Stocks to Invest in Now. The stock has gained by over 16% in the past month, with a major surge following the June 12 announcement that the company had agreed to be acquired by BioNTec... Full story

Yahoo Finance • 6 months ago

Deutsche Bank bearish on European pharma stocks into Q2 amid political headwinds

Investing.com -- Deutsche Bank has made several rating and target price adjustments across the European pharmaceuticals space ahead of second-quarter earnings, flagging continued weakness in the sector and potential opportunities in select... Full story

Yahoo Finance • 7 months ago

CureVac stock downgraded to neutral by UBS after BioNTech acquisition

Investing.com - UBS downgraded CureVac (NASDAQ:CVAC) from Buy to Neutral on Thursday, lowering its price target to $5.50 from $12.00 following the company’s acquisition by BioNTech (NASDAQ:BNTX). According to InvestingPro data, CureVac mai... Full story

Yahoo Finance • 7 months ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 7 months ago

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. (NASDAQ: CVAC)

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story

Yahoo Finance • 7 months ago

Notable healthcare headlines for the week: Novo Nordisk, Thermo Fisher and UnitedHealth in focus

Wall Street's major averages plummeted on Friday after Israel and Iran traded missile strikes and stoked concerns of an all-out war in the Middle East. Iran retaliated on Friday with its own projectiles after Israel’s attack on some of Ir... Full story

Yahoo Finance • 7 months ago

Key deals this week: BioNTech, UnitedHealth, Qualcomm, Papa John's and more

[Top view of business office workstation with M&A letters or merger and acquisition] Atstock Productions Here's a list of key deals reported across sectors this week: BioNTech (NASDAQ:BNTX [https://seekingalpha.com/symbol/BNTX]) has agre... Full story

Yahoo Finance • 7 months ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story